Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04445506 · ClinicalTrials.gov registry record
Short Term Corticosteroids in SARS-CoV2 Patients
A clinical trial, sponsored by The Miriam Hospital.
- Completed
- Registry status
- 50
- Enrollment target
NCT04445506: Completed study, sponsored by The Miriam Hospital.
NCT04445506 is a clinical trial that has completed, run by The Miriam Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04445506 has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The investigators reviewed the charts of SARS-CoV-2 patients with pneumonia and moderate to severely elevated CRP and worsening hypoxemia who were treated with early, short-term dexamethasone.
Interventions
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2020-05-31 |
What the finished NCT04445506 record still lists
NCT04445506 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone is the first listed.
NCT04445506 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04445506 about?
NCT04445506 is a clinical study titled "Short Term Corticosteroids in SARS-CoV2 Patients". The investigators reviewed the charts of SARS-CoV-2 patients with pneumonia and moderate to severely elevated CRP and worsening hypoxemia who were treated with early, short-term dexamethasone.
What is the current status of trial NCT04445506?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2020-04-01. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT04445506?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT04445506?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI